The Guardian view on de-extinction: Jurassic Park may be becoming reality
By Editorial,
The Guardian
| 08. 19. 2022
We should be keeping endangered species alive rather than bringing animals back from extinction
"tasmanian tiger" by nicolas.boullosa is licensed under CC BY 2.0.
The last official sighting of a Tasmanian tiger in the wild occurred in 1930, when it was shot by a farmer. The marsupials, formally known as thylacines, were hunted to extinction by European settlers who considered them a threat to their sheep and poultry. However, the 6ft-long creatures may reappear if a group of biotechnologists have their way.
The company Colossal Biosciences, along with researchers from the University of Melbourne, plans to “de-extinct” the thylacine by using gene-editing technology. Australia has the fastest rate of mammal extinction in the world; disappearances are down to the arrival of foreign species and wildfires linked to the climate crisis. Scientists argue that in Tasmania the loss of the thylacine left the numbers of smaller marsupials unchecked, leading to over-grazing and threatening a fragile ecological balance.
If it all sounds like a plot line from Jurassic Park, then that is because the science behind the resurrection plan provided the movie’s inspiration. Last year Colossal, co-founded by a Harvard geneticist, raised...
Related Articles
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...
By Noah Fromson, HealthLab | 10.19.2026
Gene therapy is no longer the future of medicine — it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.
There are more than 6,000 rare genetic disorders but only a fraction currently have treatable targets...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...